Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

112 Press Releases
DateTitleCompany
18 Sep 17 AmpliPhi Biosciences’ CEO to Moderate Panel Discussion at Upcoming Anti-Infectives Rx Conference AmpliPhi Biosciences Corporation,
Published by
Business Wire
11 Sep 17 AmpliPhi Biosciences Announces First Intravenous Treatment of a Patient with AB-SA01 Targeting Staphylococcus aureus AmpliPhi Biosciences,
Published by
Business Wire
06 Sep 17 AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive AmpliPhi Biosciences Corporation,
Published by
Business Wire
05 Sep 17 AmpliPhi Biosciences to Present at Rodman & Renshaw 19th Annual Global Investment Conference AmpliPhi Biosciences Corporation,
Published by
Business Wire
21 Aug 17 AmpliPhi Biosciences Announces Publication of Bacteriophage Case Study for Life-Threatening Antibiotic-Resistant Infection AmpliPhi Biosciences Corporation,
Published by
Business Wire
07 Aug 17 AmpliPhi Biosciences to Hold 2017 Second Quarter and Business Update Conference Call on August 14 AmpliPhi Biosciences Corporation,
Published by
Business Wire
05 Jul 17 AmpliPhi Biosciences to Present at Bacteriophage Therapy Workshop Sponsored by the FDA and NIH AmpliPhi Biosciences Corporation,
Published by
Business Wire
14 Jun 17 AmpliPhi Biosciences Announces Presentation and Panel Participation at BIO International Convention AmpliPhi Biosciences Corporation,
Published by
Business Wire
31 May 17 AmpliPhi Biosciences Appoints Paul C. Grint, M.D. as Chief Executive Officer AmpliPhi Biosciences Corporation,
Published by
Business Wire
30 May 17 AmpliPhi Biosciences to Present at 7th Annual LD Micro Invitational Conference on June 6 AmpliPhi Biosciences Corporation,
Published by
Business Wire
11 May 17 AmpliPhi Biosciences to Hold Business Update Conference Call on May 15 AmpliPhi Biosciences Corporation,
Published by
Business Wire
11 May 17 AmpliPhi Biosciences Announces Closing of Public Offering AmpliPhi Biosciences Corporation,
Published by
Business Wire
05 May 17 AmpliPhi Biosciences Announces Pricing of $10.4 Million Underwritten Public Offering of Common Stock and Common Warrants AmpliPhi Biosciences Corporation,
Published by
Business Wire
01 May 17 AmpliPhi Biosciences Announces a New Strategic Emphasis on Personalized Therapies for Serious or Life-Threatening Antibiotic-Resistant Infections AmpliPhi Biosciences Corporation,
Published by
Business Wire
25 Apr 17 AmpliPhi Biosciences Announces Presentation of Personalized Bacteriophage Therapy Case Study for Life-Threatening Antibiotic-Resistant Infection at Scientific Conference AmpliPhi Biosciences Corporation,
Published by
Business Wire
17 Apr 17 AmpliPhi Biosciences Announces Positive Feedback from FDA on Phase 2 Development Proposal AmpliPhi Biosciences,
Published by
Business Wire
14 Apr 17 AmpliPhi Biosciences Announces Planned One-for-Ten Reverse Stock Split AmpliPhi Biosciences Corporation,
Published by
Business Wire
04 Apr 17 AmpliPhi Biosciences Announces Presentations of Clinical and Preclinical Data from Studies with its Bacteriophage Technology at Two Scientific Conferences AmpliPhi Biosciences Corporation,
Published by
Business Wire
01 Nov 16 AmpliPhi Biosciences Granted Small and Medium Enterprise Status by European Medicines Agency AmpliPhi Biosciences Corporation,
Published by
Business Wire
26 Oct 16 AmpliPhi Biosciences Announces Favorable Topline Safety and Tolerability Results from Its Phase 1 Trial in Patients with Chronic Rhinosinusitis AmpliPhi Biosciences ,
Published by
PharmiWeb.com
14 Nov 16 AmpliPhi Biosciences Announces Settlement of Pending Lawsuit AmpliPhi Biosciences Corporation,
Published by
Business Wire
17 Nov 16 AmpliPhi Biosciences Announces Pricing of Public Offering of Common Stock and Warrants AmpliPhi Biosciences Corporation,
Published by
Business Wire
05 Dec 16 CORRECTING and REPLACING AmpliPhi Biosciences Reports Favorable Final Results From Phase 1 Trial of AB-SA01 AmpliPhi Biosciences Corporation,
Published by
Business Wire
05 Dec 16 AmpliPhi Biosciences Reports Favorable Final Results From Phase 1 Trial of AB-SA01 AmpliPhi Biosciences Corporation AmpliPhi Biosciences Corporation,
Published by
Business Wire
30 Jan 17 AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer AmpliPhi Biosciences Corporation,
Published by
Business Wire
19 Dec 16 AmpliPhi Biosciences Reports Favorable Final Results From Phase 1 Trial of AB-SA01 in Chronic Rhinosinusitis Patients AmpliPhi Biosciences Corporation,
Published by
Business Wire
04 Jan 17 Renowned Sinus Surgeon Dr. Peter-John Wormald Comments on AmpliPhi Biosciences’ Favorable Phase 1 Results of AB-SA01 in Chronic Rhinosinusitis Patients AmpliPhi Biosciences Corporation,
Published by
Business Wire
07 Mar 17 AmpliPhi Biosciences to Present at the 29th Annual ROTH Investor Conference AmpliPhi Biosciences Corporation,
Published by
Business Wire
06 Feb 17 AmpliPhi Biosciences to Present at the 19th Annual BIO CEO and Investor Conference AmpliPhi Biosciences Corporation,
Published by
Business Wire
23 Feb 17 AmpliPhi Biosciences Establishes Scientific Advisory Board and Appoints Dr. Timothy Lu of MIT and Broad Institute as SAB Chairman AmpliPhi Biosciences Corporation,
Published by
Business Wire
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.